✦ LIBER ✦

A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome: Presence of CD55−CD59−Blood Cells Predicts Platelet Response

✍ Scribed by Takayuki Ishikawa; Kaoru Tohyama; Shinji Nakao; Yataro Yoshida; Masanao Teramura; Toshiko Motoji; Masaaki Takatoku; Mineo Kurokawa; Kinuko Mitani; Takashi Uchiyama; Mitsuhiro Omine

Book ID: 111835710
Publisher: Carden Jennings Publishing
Year: 2007
Tongue: English
Weight: 142 KB
Volume: 86
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.07052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Favourable response to antithymocyte or

Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a ‘non-clonal’ pattern of X-chromosome inactivation in bone marrow cells

✍ M. Aivado; A. Rong; M. Stadler; U. Germing; A. Giagounidis; C. Strupp; J. Novotn 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide

✍ Eunice S Wang, Roger M Lyons, Richard A Larson, Sunil Gandhi, Delong Liu, Carmen 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 369 KB